Tagomics Ltd.
PrivateLast Round
Series A
Feb 21, 2024
Total Funding Raised
$10.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Tagomics Ltd. operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series A round in February 2024.
Tagomics Ltd. is a biotechnology company that develops a multiomic profiling platform for biomarker discovery and disease diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tagomics Ltd. Comparables
Compare Tagomics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precede Biosciences | 81% | |
| biomodal | 81% | |
| ClearNote Health | 79% |
For institutional investors. Book with your work email.
Tagomics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 21, 2024 | ||||
| Pre Seed | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tagomics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start Codon | Pre Seed |
| Agilent Ventures | Series A |
| OMX Ventures | Series A |
| IQ Capital | Series A, Pre Seed |
| Innovate UK | Pre Seed |
| Calculus Capital | Series A |
| Mercia Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 13, representing 50% of headcount.
- Aug 22, 2026
Grew 24% QoQ, from 21 to 26 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 18, 2026
Tagomics Ltd. is developing LiquiPath through projects with pharmaceutical companies, including AstraZeneca, across therapeutic areas and stages of drug development; the platform analyzes circulating cell-free DNA to identify treatment-related effects across multiple organs, and an early access programme supports priority applications, validation studies, and future development.
- launchesAug 17, 2026
Tagomics Ltd. launches LiquiPath(TM), a cross-species, multi-organ liquid pathology platform for non-invasive drug safety monitoring, with an early access program open on Aug 17th '26.
For institutional investors. Book with your work email.
Tagomics Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tagomics Ltd.'s valuation, stock price, and market status.
Is Tagomics Ltd. a public or private company?
Tagomics Ltd. is a private company.
What is the current stock price of Tagomics Ltd.?
Tagomics Ltd. is a private company, so its shares have no public market price. Caplight tracks Tagomics Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tagomics Ltd. worth (valuation)?
Valuation information for Tagomics Ltd. is not publicly available.
Can I buy Tagomics Ltd. stock?
Tagomics Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tagomics Ltd.'s last funding round?
Tagomics Ltd.'s most recent funding round was Series A on February 21, 2024.
Who are the main investors in Tagomics Ltd.?
Key investors in Tagomics Ltd. include Start Codon, IQ Capital, Calculus Capital.
Will Tagomics Ltd. IPO soon?
No public IPO plans have been announced for Tagomics Ltd..
How can I track Tagomics Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Tagomics Ltd.'s shares on secondary markets.